Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ASP.TO Stock Summary
In the News
ASP.TO Financial details
Company Rating
Neutral
Market Cap
2.77M
Income
-32.27M
Revenue
3.04M
Book val./share
-1.8
Cash/share
0.39
Dividend
-
Dividend %
-
Employees
14
Optionable
No
Shortable
Yes
Earnings
08 May 2023
P/E
-0.09
Forward P/E
-
PEG
0.01
P/S
0.9
P/B
-0.15
P/C
0.92
P/FCF
-0.1
Quick Ratio
0.27
Current Ratio
0.67
Debt / Equity
-3.32
LT Debt / Equity
-3.32
-
-
EPS (TTM)
-4.19
EPS next Y
-
EPS next Q
-
EPS this Y
-72.4%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-8.35%
Revenue last 5Y
NAN%
Revenue Q/Q
2.94%
EPS Q/Q
-37.82%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
0.99%
Inst Trans
1%
ROA
-49%
ROE
231%
ROC
-0.46%
Gross Margin
59%
Oper. Margin
-644%
Profit Margin
-1014%
Payout
-
Shs Outstand
7.71M
Shs Float
7.62M
-
-
-
-
Target Price
-
52W Range
0.28-10.0
52W High
-
52W Low
-
RSI
27
Rel Volume
0.96
Avg Volume
1.3K
Volume
1.25K
Perf Week
0%
Perf Month
28.57%
Perf Quarter
-
Perf Half Y
-74.65%
-
-
-
-
Beta
1.028
-
-
Volatility
0%, 0.03%
Prev Close
0%
Price
0.36
Change
0%
ASP.TO Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
Metric | History | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 5.27 | 5.73 | 2.58 | 0.74 | -0.54 | |
Net income per share | -7.13 | -14.59 | -11.03 | -16.7 | -4.61 | |
Operating cash flow per share | 0.08 | -4.76 | -7.78 | -15.15 | -3.06 | |
Free cash flow per share | 0.08 | -4.95 | -7.86 | -15.15 | -3.07 | |
Cash per share | 2.58 | 2.97 | 4.01 | 6.26 | 0.28 | |
Book value per share | 4.84 | -0.06 | -8.77 | 2.16 | -3.38 | |
Tangible book value per share | -5.44 | -6.22 | -12.11 | 0.7 | -3.43 | |
Share holders equity per share | 4.84 | -0.06 | -8.77 | 2.16 | -3.38 | |
Interest debt per share | 4.04 | 7.26 | 14.89 | 6.7 | 3.28 | |
Market cap | 350.62K | 339.62K | 405.25K | 413.52K | 2.17M | |
Enterprise value | 1.76M | 4.8M | 14.64M | -491.48K | 23.62M | |
P/E ratio | -0.04 | -0.02 | -0.03 | -0.02 | -0.06 | |
Price to sales ratio | 0.05 | 0.05 | 0.11 | 0.38 | -0.53 | |
POCF ratio | 3.54 | -0.06 | -0.04 | -0.02 | -0.09 | |
PFCF ratio | 3.54 | -0.05 | -0.04 | -0.02 | -0.09 | |
P/B Ratio | 0.06 | -4.78 | -0.03 | 0.13 | -0.08 | |
PTB ratio | 0.06 | -4.78 | -0.03 | 0.13 | -0.08 | |
EV to sales | 0.27 | 0.65 | 3.88 | -0.45 | -5.71 | |
Enterprise value over EBITDA | -0.28 | -0.3 | -1.1 | 0.02 | -0.75 | |
EV to operating cash flow | 17.81 | -0.78 | -1.29 | 0.02 | -1 | |
EV to free cash flow | 17.81 | -0.75 | -1.27 | 0.02 | -1 | |
Earnings yield | -24.85 | -55.31 | -39.8 | -59.06 | -16.33 | |
Free cash flow yield | 0.28 | -18.77 | -28.37 | -53.61 | -10.86 | |
Debt to equity | 0.77 | -116.72 | -1.57 | 2.61 | -0.91 | |
Debt to assets | 0.21 | 0.49 | 1.3 | 0.49 | 2.45 | |
Net debt to EBITDA | -0.23 | -0.28 | -1.07 | 0.04 | -0.68 | |
Current ratio | 1.52 | 1.35 | 1.23 | 1.98 | 0.72 | |
Interest coverage | -18.79 | -13.08 | -6.79 | -13.7 | -19.63 | |
Income quality | -0.01 | 0.33 | 0.71 | 0.91 | 0.7 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0.84 | 1.42 | 5.17 | -1.7 | |
Research and developement to revenue | 0.34 | 0.33 | 0.75 | 2.33 | -1.59 | |
Intangibles to total assets | 0.56 | 0.47 | 0.32 | 0.13 | 0.03 | |
Capex to operating cash flow | 0 | 0.04 | 0.01 | 0 | 0 | |
Capex to revenue | 0 | -0.03 | -0.03 | 0 | 0.02 | |
Capex to depreciation | 0 | -0.13 | -0.1 | 0 | -0.11 | |
Stock based compensation to revenue | 0.09 | 0.06 | 0.05 | 0.6 | -0.26 | |
Graham number | 27.86 | 4.25 | 46.65 | 28.49 | 18.74 | |
ROIC | -0.67 | -1.69 | -1.2 | -1.71 | 16.13 | |
Return on tangible assets | -0.9 | -2.11 | -1.53 | -1.65 | -3.81 | |
Graham Net | -8.43 | -8.53 | -14.48 | -1.65 | -4.02 | |
Working capital | 2.79M | 1.96M | 1.73M | 6.93M | -3.42M | |
Tangible asset value | -6.65M | -8M | -17.72M | 1.02M | -26.35M | |
Net current asset value | -8.13M | -9.27M | -19.04M | 212K | -27.02M | |
Invested capital | 0.77 | -116.72 | -1.57 | 2.61 | -0.91 | |
Average receivables | 3.53M | 1.48M | 878.5K | 1.05M | 943K | |
Average payables | 1.41M | 1.3M | 1.2M | 1.05M | 2.08M | |
Average inventory | 3.37M | 2.74M | 2M | 1.9M | 3.46M | |
Days sales outstanding | 104.33 | 55.07 | 62.38 | 492.5 | -37.27 | |
Days payables outstanding | 135.69 | 48.72 | 167.98 | 197.18 | 1K | |
Days of inventory on hand | 333.23 | 88.6 | 247.98 | 419.19 | 1.5K | |
Receivables turnover | 3.5 | 6.63 | 5.85 | 0.74 | -9.79 | |
Payables turnover | 2.69 | 7.49 | 2.17 | 1.85 | 0.36 | |
Inventory turnover | 1.1 | 4.12 | 1.47 | 0.87 | 0.24 | |
ROE | -1.47 | 264.59 | 1.26 | -7.73 | 1.36 | |
Capex per share | 0 | -0.19 | -0.08 | 0 | -0.01 |
Quarterly Fundamentals Overview
Last date of statement is 2022-09-30 for Q3
Metric | History | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.08 | 0.1 | 0.1 | 0.1 | 0.1 | |
Net income per share | -0.64 | -1.16 | -1.1 | -1.19 | -0.74 | |
Operating cash flow per share | -0.59 | -0.94 | -0.61 | -0.79 | -1.02 | |
Free cash flow per share | -0.59 | -0.95 | -0.7 | -0.89 | -1.07 | |
Cash per share | 0.3 | 0.28 | 0.46 | 0.17 | 0.39 | |
Book value per share | -2.42 | -3.38 | -0.6 | -1.52 | -1.8 | |
Tangible book value per share | -2.68 | -3.43 | -5.37 | -6.28 | -6.56 | |
Share holders equity per share | -2.42 | -3.38 | -0.6 | -1.52 | -1.8 | |
Interest debt per share | 2.34 | 3.06 | 4.78 | 5.4 | 6.19 | |
Market cap | 2.19M | 2.17M | 2.21M | 2.15M | 2.03M | |
Enterprise value | 16.93M | 23.62M | 33.97M | 41.22M | 45.14M | |
P/E ratio | -0.11 | -0.06 | -0.07 | -0.06 | -0.09 | |
Price to sales ratio | 3.73 | 2.94 | 2.83 | 2.87 | 2.63 | |
POCF ratio | -0.49 | -0.3 | -0.47 | -0.36 | -0.26 | |
PFCF ratio | -0.49 | -0.3 | -0.41 | -0.31 | -0.25 | |
P/B Ratio | -0.12 | -0.08 | -0.48 | -0.18 | -0.15 | |
PTB ratio | -0.12 | -0.08 | -0.48 | -0.18 | -0.15 | |
EV to sales | 28.84 | 32 | 43.44 | 55.11 | 58.62 | |
Enterprise value over EBITDA | -4.44 | -2.62 | -6.27 | -6.22 | -17.45 | |
EV to operating cash flow | -3.75 | -3.26 | -7.29 | -6.82 | -5.73 | |
EV to free cash flow | -3.75 | -3.23 | -6.34 | -6.01 | -5.46 | |
Earnings yield | -2.24 | -4.12 | -3.81 | -4.27 | -2.81 | |
Free cash flow yield | -2.06 | -3.37 | -2.42 | -3.19 | -4.08 | |
Debt to equity | -0.91 | -0.91 | -7.66 | -3.45 | -3.32 | |
Debt to assets | 1.5 | 2.45 | 0.74 | 0.89 | 0.97 | |
Net debt to EBITDA | -3.87 | -2.38 | -5.86 | -5.9 | -16.66 | |
Current ratio | 0.71 | 0.72 | 0.49 | 0.37 | 0.67 | |
Interest coverage | -6.24 | 133.69 | -3.72 | -5.32 | -1.73 | |
Income quality | 0.92 | 0.8 | 0.67 | 0.76 | 1.89 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 2.3 | 4.48 | 1.65 | 2.99 | 2.51 | |
Intangibles to total assets | 0.18 | 0.03 | 0.77 | 0.81 | 0.77 | |
Capex to operating cash flow | 0 | 0.01 | 0.15 | 0.13 | 0.05 | |
Capex to revenue | 0 | -0.08 | -0.89 | -1.09 | -0.51 | |
Capex to depreciation | 0 | -0.75 | -12.19 | -14.52 | -6.91 | |
Stock based compensation to revenue | 0.57 | 0.4 | 0.3 | 0.24 | 0.12 | |
Graham number | 5.89 | 9.42 | 3.84 | 6.39 | 5.48 | |
ROIC | 7.33 | 4.31 | -0.21 | -0.27 | -0.11 | |
Return on tangible assets | -0.53 | -0.96 | -0.76 | -1.05 | -0.52 | |
Graham Net | -3.24 | -4.02 | -6 | -6.86 | -7.16 | |
Working capital | -3.55M | -3.42M | -10.78M | -13.62M | -5.04M | |
Tangible asset value | -20.64M | -26.35M | -41.27M | -48.36M | -50.53M | |
Net current asset value | -21.29M | -27.02M | -41.98M | -49.02M | -51.15M | |
Invested capital | -0.91 | -0.91 | -7.66 | -3.45 | -3.32 | |
Average receivables | 1.76M | 1.31M | 530.5K | 833K | 1.08M | |
Average payables | 1.72M | 2.66M | 3.09M | 2.99M | 2.59M | |
Average inventory | 2.39M | 3.46M | 4.52M | 4.49M | 4.84M | |
Days sales outstanding | 337.16 | 51.46 | 73.54 | 123.57 | 132.19 | |
Days payables outstanding | 412.45 | 703.74 | 1.12K | 534.95 | 1.04K | |
Days of inventory on hand | 426.26 | 1.05K | 1.59K | 851.35 | 2.28K | |
Receivables turnover | 0.27 | 1.75 | 1.22 | 0.73 | 0.68 | |
Payables turnover | 0.22 | 0.13 | 0.08 | 0.17 | 0.09 | |
Inventory turnover | 0.21 | 0.09 | 0.06 | 0.11 | 0.04 | |
ROE | 0.26 | 0.34 | 1.83 | 0.78 | 0.41 | |
Capex per share | 0 | -0.01 | -0.09 | -0.11 | -0.05 |
ASP.TO Frequently Asked Questions
What is Acerus Pharmaceuticals Corporation stock symbol ?
Acerus Pharmaceuticals Corporation is a CA stock , located in Mississauga of On and trading under the symbol ASP.TO
What is Acerus Pharmaceuticals Corporation stock quote today ?
Acerus Pharmaceuticals Corporation stock price is $0.36 today.
Is Acerus Pharmaceuticals Corporation stock public?
Yes, Acerus Pharmaceuticals Corporation is a publicly traded company.